Regarding "Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions".
Meerwaldt
Robbert
R
Blomme
Adri
A
Fritschy
Wilbert
W
Zeebregts
Clark J
CJ
D001157:Arterial Occlusive Diseases / Q000150:complications / Q000378:metabolism / Q000503:physiopathology / Q000601:surgery*; D019917:Blood Vessel Prosthesis Implantation; D003251:Constriction, Pathologic; D003925:Diabetic Angiopathies / Q000378:metabolism / Q000503:physiopathology / Q000601:surgery*; D005263:Femoral Artery / Q000503:physiopathology / Q000601:surgery*; D017127:Glycation End Products, Advanced / Q000097:blood; D006801:Humans; D007383:Intermittent Claudication / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology / Q000601:surgery; D007511:Ischemia / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology / Q000601:surgery; D023821:Limb Salvage; D035002:Lower Extremity / Q000098:blood supply; D011446:Prospective Studies; D012008:Recurrence; D012307:Risk Factors; D017211:Treatment Failure; D014654:Vascular Patency
D017127:Glycation End Products, Advanced